Annual Net Income
-$8.40 M
+$2.11 M+20.10%
December 31, 2023
Summary
- As of February 7, 2025, MNPR annual net profit is -$8.40 million, with the most recent change of +$2.11 million (+20.10%) on December 31, 2023.
- During the last 3 years, MNPR annual net income has fallen by -$2.10 million (-33.27%).
- MNPR annual net income is now -608.69% below its all-time high of -$1.19 million, reached on December 31, 2016.
Performance
MNPR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$1.30 M
+$411.00 K+23.96%
September 30, 2024
Summary
- As of February 7, 2025, MNPR quarterly net profit is -$1.30 million, with the most recent change of +$411.00 thousand (+23.96%) on September 30, 2024.
- Over the past year, MNPR quarterly net income has increased by +$336.90 thousand (+20.53%).
- MNPR quarterly net income is now -249.77% below its all-time high of -$372.90 thousand, reached on March 31, 2017.
Performance
MNPR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$6.47 M
+$649.40 K+9.12%
September 30, 2024
Summary
- As of February 7, 2025, MNPR TTM net profit is -$6.47 million, with the most recent change of +$649.40 thousand (+9.12%) on September 30, 2024.
- Over the past year, MNPR TTM net income has increased by +$1.13 million (+14.91%).
- MNPR TTM net income is now -1636.31% below its all-time high of -$372.90 thousand, reached on March 31, 2017.
Performance
MNPR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
MNPR Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +20.1% | +20.5% | +14.9% |
3 y3 years | -33.3% | +47.0% | +24.3% |
5 y5 years | -160.3% | +30.8% | +8.8% |
MNPR Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +20.1% | at high | +55.0% | at high | +38.4% |
5 y | 5-year | -98.9% | +20.1% | -19.6% | +55.0% | -64.3% | +38.4% |
alltime | all time | -608.7% | +49.3% | -249.8% | +91.2% | -1636.3% | +62.5% |
Monopar Therapeutics Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.30 M(-24.0%) | -$6.47 M(-9.1%) |
Jun 2024 | - | -$1.72 M(+4.5%) | -$7.12 M(-6.4%) |
Mar 2024 | - | -$1.64 M(-9.5%) | -$7.61 M(-9.4%) |
Dec 2023 | -$8.40 M(-20.1%) | -$1.81 M(-7.2%) | -$8.40 M(-11.4%) |
Sep 2023 | - | -$1.95 M(-11.2%) | -$9.48 M(-4.5%) |
Jun 2023 | - | -$2.20 M(-9.6%) | -$9.93 M(-5.4%) |
Mar 2023 | - | -$2.43 M(-15.9%) | -$10.49 M(-0.2%) |
Dec 2022 | -$10.52 M(+15.5%) | -$2.90 M(+20.7%) | -$10.52 M(+2.1%) |
Sep 2022 | - | -$2.40 M(-13.1%) | -$10.30 M(-0.6%) |
Jun 2022 | - | -$2.76 M(+12.5%) | -$10.36 M(+7.1%) |
Mar 2022 | - | -$2.46 M(-8.4%) | -$9.68 M(+6.3%) |
Dec 2021 | -$9.10 M(+44.4%) | -$2.68 M(+9.0%) | -$9.10 M(+6.5%) |
Sep 2021 | - | -$2.46 M(+18.2%) | -$8.55 M(+10.6%) |
Jun 2021 | - | -$2.08 M(+10.4%) | -$7.73 M(+8.9%) |
Mar 2021 | - | -$1.88 M(-11.5%) | -$7.10 M(+12.6%) |
Dec 2020 | -$6.30 M | -$2.13 M(+29.8%) | -$6.30 M(+17.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | -$1.64 M(+13.4%) | -$5.38 M(+20.2%) |
Jun 2020 | - | -$1.45 M(+32.5%) | -$4.48 M(+13.7%) |
Mar 2020 | - | -$1.09 M(-9.6%) | -$3.94 M(-6.8%) |
Dec 2019 | -$4.22 M(+30.9%) | -$1.21 M(+64.0%) | -$4.22 M(+8.1%) |
Sep 2019 | - | -$736.10 K(-18.7%) | -$3.91 M(+2.5%) |
Jun 2019 | - | -$905.70 K(-34.2%) | -$3.81 M(+2.3%) |
Mar 2019 | - | -$1.38 M(+54.5%) | -$3.73 M(+15.5%) |
Dec 2018 | -$3.23 M(-80.5%) | -$890.50 K(+39.1%) | -$3.23 M(+5.8%) |
Sep 2018 | - | -$640.20 K(-22.0%) | -$3.05 M(-82.4%) |
Jun 2018 | - | -$820.90 K(-6.3%) | -$17.29 M(+1.3%) |
Mar 2018 | - | -$876.30 K(+22.8%) | -$17.06 M(+3.0%) |
Dec 2017 | -$16.55 M(+1296.3%) | -$713.60 K(-95.2%) | -$16.55 M(+4.5%) |
Sep 2017 | - | -$14.88 M(+2415.5%) | -$15.84 M(+1542.8%) |
Jun 2017 | - | -$591.40 K(+58.6%) | -$964.30 K(+158.6%) |
Mar 2017 | - | -$372.90 K | -$372.90 K |
Dec 2016 | -$1.19 M | - | - |
FAQ
- What is Monopar Therapeutics annual net profit?
- What is the all time high annual net income for Monopar Therapeutics?
- What is Monopar Therapeutics annual net income year-on-year change?
- What is Monopar Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly net income year-on-year change?
- What is Monopar Therapeutics TTM net profit?
- What is the all time high TTM net income for Monopar Therapeutics?
- What is Monopar Therapeutics TTM net income year-on-year change?
What is Monopar Therapeutics annual net profit?
The current annual net income of MNPR is -$8.40 M
What is the all time high annual net income for Monopar Therapeutics?
Monopar Therapeutics all-time high annual net profit is -$1.19 M
What is Monopar Therapeutics annual net income year-on-year change?
Over the past year, MNPR annual net profit has changed by +$2.11 M (+20.10%)
What is Monopar Therapeutics quarterly net profit?
The current quarterly net income of MNPR is -$1.30 M
What is the all time high quarterly net income for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly net profit is -$372.90 K
What is Monopar Therapeutics quarterly net income year-on-year change?
Over the past year, MNPR quarterly net profit has changed by +$336.90 K (+20.53%)
What is Monopar Therapeutics TTM net profit?
The current TTM net income of MNPR is -$6.47 M
What is the all time high TTM net income for Monopar Therapeutics?
Monopar Therapeutics all-time high TTM net profit is -$372.90 K
What is Monopar Therapeutics TTM net income year-on-year change?
Over the past year, MNPR TTM net profit has changed by +$1.13 M (+14.91%)